Search research articles
Contact Us
Filters
Showing results (61-70 of 90) with videos related to
Page
of 9
Sort By:
Clinical Pharmacology and Therapeutics
|
December 15, 2025
Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization
Zrinka Duvnjak, Robin Michelet, Casper Steenholdt, et al.
Pharmaceutics
|
December 28, 2021
Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing-A Translational Example for Intensive Care Units
Ferdinand Anton Weinelt, Miriam Songa Stegemann, Anja Theloe, et al.
British Journal of Clinical Pharmacology
|
October 23, 2021
Evaluating prediction methods for glomerular filtration to optimise drug doses in obese and nonobese patients
David Busse, Jens Markus Borghardt, David Petroff, et al.
Clinical Pharmacokinetics
|
December 11, 2021
Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
David Busse, Philipp Simon, Lisa Schmitt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 3, 2020
Quantification of microdialysis related variability in humans: Clinical trial design recommendations
David Busse, Philipp Simon, Robin Michelet, et al.
Frontiers in Pharmacology
|
January 30, 2023
Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach
Robin Michelet, Davide Bindellini, Johanna Melin, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 14, 2023
A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non-small cell lung cancer patients
Francis Williams Ojara, Andrea Henrich, Nicolas Frances, et al.
Clinical Pharmacokinetics
|
October 4, 2022
Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion
Yomna M Nassar, Nicolas Hohmann, Robin Michelet, et al.
Cancers
|
November 25, 2023
C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework
Yomna M Nassar, Francis Williams Ojara, Alejandro Pérez-Pitarch, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 8, 2024
A quantitative modeling framework to understand the physiology of the hypothalamic-pituitary-adrenal axis and interaction with cortisol replacement therapy
Davide Bindellini, Robin Michelet, Linda B S Aulin, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 90) with videos related to
Sort By:
Page
of 9
Clinical Pharmacology and Therapeutics
|
December 15, 2025
Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization
Zrinka Duvnjak, Robin Michelet, Casper Steenholdt, et al.
Pharmaceutics
|
December 28, 2021
Development of a Model-Informed Dosing Tool to Optimise Initial Antibiotic Dosing-A Translational Example for Intensive Care Units
Ferdinand Anton Weinelt, Miriam Songa Stegemann, Anja Theloe, et al.
British Journal of Clinical Pharmacology
|
October 23, 2021
Evaluating prediction methods for glomerular filtration to optimise drug doses in obese and nonobese patients
David Busse, Jens Markus Borghardt, David Petroff, et al.
Clinical Pharmacokinetics
|
December 11, 2021
Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
David Busse, Philipp Simon, Lisa Schmitt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 3, 2020
Quantification of microdialysis related variability in humans: Clinical trial design recommendations
David Busse, Philipp Simon, Robin Michelet, et al.
Frontiers in Pharmacology
|
January 30, 2023
Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach
Robin Michelet, Davide Bindellini, Johanna Melin, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 14, 2023
A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non-small cell lung cancer patients
Francis Williams Ojara, Andrea Henrich, Nicolas Frances, et al.
Clinical Pharmacokinetics
|
October 4, 2022
Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion
Yomna M Nassar, Nicolas Hohmann, Robin Michelet, et al.
Cancers
|
November 25, 2023
C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework
Yomna M Nassar, Francis Williams Ojara, Alejandro Pérez-Pitarch, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 8, 2024
A quantitative modeling framework to understand the physiology of the hypothalamic-pituitary-adrenal axis and interaction with cortisol replacement therapy
Davide Bindellini, Robin Michelet, Linda B S Aulin, et al.
Page
of 9